Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition

Enas Sheik-Khalil, Mark Anthony Bray, Gülsen Özkaya Şahin, Gabriella Scarlatti, Marianne Jansson, Anne E. Carpenter, Eva Maria Fenyö

Research output: Contribution to journalArticle

Abstract

Background: Standardized techniques to detect HIV-neutralizing antibody responses are of great importance in the search for an HIV vaccine. Methods: Here, we present a high-throughput, high-content automated plaque reduction (APR) assay based on automated microscopy and image analysis that allows evaluation of neutralization and inhibition of cell-cell fusion within the same assay. Neutralization of virus particles is measured as a reduction in the number of fluorescent plaques, and inhibition of cell-cell fusion as a reduction in plaque area. Results: We found neutralization strength to be a significant factor in the ability of virus to form syncytia. Further, we introduce the inhibitory concentration of plaque area reduction (ICpar) as an additional measure of antiviral activity, i.e. fusion inhibition. Conclusions: We present an automated image based high-throughput, high-content HIV plaque reduction assay. This allows, for the first time, simultaneous evaluation of neutralization and inhibition of cell-cell fusion within the same assay, by quantifying the reduction in number of plaques and mean plaque area, respectively. Inhibition of cell-to-cell fusion requires higher quantities of inhibitory reagent than inhibition of virus neutralization.

Original languageEnglish
Article number472
JournalBMC Infectious Diseases
Volume14
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Cell Fusion
HIV
Viruses
AIDS Vaccines
HIV Antibodies
Giant Cells
Neutralizing Antibodies
Virion
Antibody Formation
Antiviral Agents
Microscopy

Keywords

  • Automated plaque reduction assay (APR assay)
  • Fluorescence
  • Fusion inhibition
  • HIV
  • Neutralization

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Sheik-Khalil, E., Bray, M. A., Şahin, G. Ö., Scarlatti, G., Jansson, M., Carpenter, A. E., & Fenyö, E. M. (2014). Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition. BMC Infectious Diseases, 14(1), [472]. https://doi.org/10.1186/1471-2334-14-472

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition. / Sheik-Khalil, Enas; Bray, Mark Anthony; Şahin, Gülsen Özkaya; Scarlatti, Gabriella; Jansson, Marianne; Carpenter, Anne E.; Fenyö, Eva Maria.

In: BMC Infectious Diseases, Vol. 14, No. 1, 472, 2014.

Research output: Contribution to journalArticle

Sheik-Khalil, Enas ; Bray, Mark Anthony ; Şahin, Gülsen Özkaya ; Scarlatti, Gabriella ; Jansson, Marianne ; Carpenter, Anne E. ; Fenyö, Eva Maria. / Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition. In: BMC Infectious Diseases. 2014 ; Vol. 14, No. 1.
@article{2a35b525e44044c7b122bd71c7b4afd2,
title = "Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition",
abstract = "Background: Standardized techniques to detect HIV-neutralizing antibody responses are of great importance in the search for an HIV vaccine. Methods: Here, we present a high-throughput, high-content automated plaque reduction (APR) assay based on automated microscopy and image analysis that allows evaluation of neutralization and inhibition of cell-cell fusion within the same assay. Neutralization of virus particles is measured as a reduction in the number of fluorescent plaques, and inhibition of cell-cell fusion as a reduction in plaque area. Results: We found neutralization strength to be a significant factor in the ability of virus to form syncytia. Further, we introduce the inhibitory concentration of plaque area reduction (ICpar) as an additional measure of antiviral activity, i.e. fusion inhibition. Conclusions: We present an automated image based high-throughput, high-content HIV plaque reduction assay. This allows, for the first time, simultaneous evaluation of neutralization and inhibition of cell-cell fusion within the same assay, by quantifying the reduction in number of plaques and mean plaque area, respectively. Inhibition of cell-to-cell fusion requires higher quantities of inhibitory reagent than inhibition of virus neutralization.",
keywords = "Automated plaque reduction assay (APR assay), Fluorescence, Fusion inhibition, HIV, Neutralization",
author = "Enas Sheik-Khalil and Bray, {Mark Anthony} and Şahin, {G{\"u}lsen {\"O}zkaya} and Gabriella Scarlatti and Marianne Jansson and Carpenter, {Anne E.} and Feny{\"o}, {Eva Maria}",
year = "2014",
doi = "10.1186/1471-2334-14-472",
language = "English",
volume = "14",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition

AU - Sheik-Khalil, Enas

AU - Bray, Mark Anthony

AU - Şahin, Gülsen Özkaya

AU - Scarlatti, Gabriella

AU - Jansson, Marianne

AU - Carpenter, Anne E.

AU - Fenyö, Eva Maria

PY - 2014

Y1 - 2014

N2 - Background: Standardized techniques to detect HIV-neutralizing antibody responses are of great importance in the search for an HIV vaccine. Methods: Here, we present a high-throughput, high-content automated plaque reduction (APR) assay based on automated microscopy and image analysis that allows evaluation of neutralization and inhibition of cell-cell fusion within the same assay. Neutralization of virus particles is measured as a reduction in the number of fluorescent plaques, and inhibition of cell-cell fusion as a reduction in plaque area. Results: We found neutralization strength to be a significant factor in the ability of virus to form syncytia. Further, we introduce the inhibitory concentration of plaque area reduction (ICpar) as an additional measure of antiviral activity, i.e. fusion inhibition. Conclusions: We present an automated image based high-throughput, high-content HIV plaque reduction assay. This allows, for the first time, simultaneous evaluation of neutralization and inhibition of cell-cell fusion within the same assay, by quantifying the reduction in number of plaques and mean plaque area, respectively. Inhibition of cell-to-cell fusion requires higher quantities of inhibitory reagent than inhibition of virus neutralization.

AB - Background: Standardized techniques to detect HIV-neutralizing antibody responses are of great importance in the search for an HIV vaccine. Methods: Here, we present a high-throughput, high-content automated plaque reduction (APR) assay based on automated microscopy and image analysis that allows evaluation of neutralization and inhibition of cell-cell fusion within the same assay. Neutralization of virus particles is measured as a reduction in the number of fluorescent plaques, and inhibition of cell-cell fusion as a reduction in plaque area. Results: We found neutralization strength to be a significant factor in the ability of virus to form syncytia. Further, we introduce the inhibitory concentration of plaque area reduction (ICpar) as an additional measure of antiviral activity, i.e. fusion inhibition. Conclusions: We present an automated image based high-throughput, high-content HIV plaque reduction assay. This allows, for the first time, simultaneous evaluation of neutralization and inhibition of cell-cell fusion within the same assay, by quantifying the reduction in number of plaques and mean plaque area, respectively. Inhibition of cell-to-cell fusion requires higher quantities of inhibitory reagent than inhibition of virus neutralization.

KW - Automated plaque reduction assay (APR assay)

KW - Fluorescence

KW - Fusion inhibition

KW - HIV

KW - Neutralization

UR - http://www.scopus.com/inward/record.url?scp=84922969792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922969792&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-14-472

DO - 10.1186/1471-2334-14-472

M3 - Article

C2 - 25176034

AN - SCOPUS:84922969792

VL - 14

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 472

ER -